Patent application number | Description | Published |
20090301613 | Low Yield Ratio Dual Phase Steel Linepipe with Superior Strain Aging Resistance - A steel composition and method from making a dual phase steel therefrom. The dual phase steel may have carbon of about 0.05% by weight to about 0.12 wt %; niobium of about 0.005 wt % to about 0.03 wt %; titanium of about 0.005 wt % to about 0.02 wt %; nitrogen of about 0.001 wt % to about 0.01 wt %; silicon of about 0.01 wt % to about 0.5 wt %; manganese of about 0.5 wt % to about 2.0 wt %; and a total of molybdenum, chromium, vanadium and copper less than about 0.15 wt %. The steel may have a first phase consisting of ferrite and a second phase having one or more of carbide, pearlite, martensite, lower bainite, granular bainite, upper bainite, and degenerate upper bainite. A solute carbon content in the first phase may be about 0.01 wt % or less. | 12-10-2009 |
20120125490 | LOW YIELD RATIO DUAL PHASE STEEL LINEPIPE WITH SUPERIOR STRAIN AGING RESISTANCE - A steel composition and method from making a dual phase steel therefrom. The dual phase steel may have carbon of about 0.05% by weight to about 0.12 wt %; niobium of about 0.005 wt % to about 0.03 wt %; titanium of about 0.005 wt % to about 0.02 wt %; nitrogen of about 0.001 wt % to about 0.01 wt %; silicon of about 0.01 wt % to about 0.5 wt %; manganese of about 0.5 wt % to about 2.0 wt %; and a total of molybdenum, chromium, vanadium and copper less than about 0.15 wt %. The steel may have a first phase consisting of ferrite and a second phase having one or more of carbide, pearlite, martensite, lower bainite, granular bainite, upper bainite, and degenerate upper bainite. A solute carbon content in the first phase may be about 0.01 wt % or less. | 05-24-2012 |
Patent application number | Description | Published |
20080245183 | Advanced erosion resistant oxide cermets - One embodiment of the invention includes a cermet composition represented by the formula (PQ)(RS) comprising: a ceramic phase (PQ) and a binder phase (RS) wherein, | 10-09-2008 |
20080257454 | COMPOSITION GRADIENT CERMETS AND REACTIVE HEAT TREATMENT PROCESS FOR PREPARING SAME - Cermets, particularly composition gradient cermets can be prepared starting with suitable bulk metal alloys by a reactive heat treatment process involving a reactive environment selected from the group consisting of reactive carbon, reactive nitrogen, reactive boron, reactive oxygen and mixtures thereof. | 10-23-2008 |
20080268230 | Advanced erosion-corrosion resistant boride cermets - A cermet composition represented by the formula (PQ)(RS) comprising: a ceramic phase (PQ) and binder phase (RS) wherein, | 10-30-2008 |
20080276757 | EROSION-CORROSION RESISTANT CARBIDE CERMETS FOR LONG TERM HIGH TEMPERATURE SERVICE - Cermets are provided in which the ceramic phase is selected from the group consisting of Cr | 11-13-2008 |
20120177933 | Multi-scale cermets for high temperature erosion-corrosion service - A cermet composition represented by the formula (PQ)(RS)X comprising: a ceramic phase (PQ), a binder phase (RS) and X wherein X is at least one member selected from the group consisting of an oxide dispersoid E, an intermetallic compound F and a derivative compound G wherein said ceramic phase (PQ) is dispersed in the binder phase (RS) as particles of diameter in the range of about 0.5 to 3000 microns, and said X is dispersed in the binder phase (RS) as particles in the size range of about 1 nm to 400 nm. | 07-12-2012 |
Patent application number | Description | Published |
20100178339 | TABLETED COMPOSITIONS CONTAINING ATAZANAVIR - Disclosed are compressed tablets containing atazanavir sulfate, optionally with another active agents, e.g., anti-HIV agents, granules that contain atazanavir sulfate and an intragranular lubricant that can be used to make the tablets, compositions comprising a plurality of the granules, processes for making the granules and tablets, and methods of treating HIV. | 07-15-2010 |
20100183715 | TABLETED COMPOSITIONS CONTAINING ATAZANAVIR - Disclosed are compressed tablets containing atazanavir sulfate, optionally with another active agents, e.g., anti-HIV agents, granules that contain atazanavir sulfate and an intragranular lubricant that can be used to make the tablets, compositions comprising a plurality of the granules, processes for making the granules and tablets, and methods of treating HIV. | 07-22-2010 |
20100183716 | TABLETED COMPOSITIONS CONTAINING ATAZANAVIR - Disclosed are compressed tablets containing atazanavir sulfate, optionally with another active agents, e.g., anti-HIV agents, granules that contain atazanavir sulfate and an intragranular lubricant that can be used to make the tablets, compositions comprising a plurality of the granules, processes for making the granules and tablets, and methods of treating HIV. | 07-22-2010 |
20120322749 | TABLETED COMPOSITIONS CONTAINING ATAZANAVIR - Disclosed are compressed tablets containing atazanavir sulfate, optionally with another active agents, e.g., anti-HIV agents, granules that contain atazanavir sulfate and an intragranular lubricant that can be used to make the tablets, compositions comprising a plurality of the granules, processes for making the granules and tablets, and methods of treating HIV. | 12-20-2012 |
20130266648 | TABLETED COMPOSITIONS CONTAINING ATAZANAVIR - Disclosed are compressed tablets containing atazanavir sulfate, optionally with another active agents, e.g., anti-HIV agents, granules that contain atazanavir sulfate and an intragranular lubricant that can be used to make the tablets, compositions comprising a plurality of the granules, processes for making the granules and tablets, and methods of treating HIV. | 10-10-2013 |
20150320731 | TABLETED COMPOSITIONS CONTAINING ATAZANAVIR - Disclosed are compressed tablets containing atazanavir sulfate, optionally with another active agents, e.g., anti-HIV agents, granules that contain atazanavir sulfate and an intragranular lubricant that can be used to make the tablets, compositions comprising a plurality of the granules, processes for making the granules and tablets, and methods of treating HIV. | 11-12-2015 |